New Research Study for PSC Patients
New research study for those that have Primary Sclerosing Cholangitis (PSC). This is a pilot, open-label study to evaluate the safety, tolerability and efficacy of Lum001 in patients with Primary Sclerosing Cholangitis. Clinical studies are necessary to learn about the safety and effectiveness of investigational medications. National laws and international regulations require that all investigational products go through clinical studies. Christopher L. Bowlus, MD, Professor of Medicine, Fellowship Program Director, Division of Gastroenterology and Hepatology of UC Davis Medical Center is the study investigator.